Tate, S., Nishikimi, K., Matsuoka, A., Otsuka, S., Kato, K., Takahashi, Y., & Shozu, M. (2020). Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: A phase II trial. J Gynecol Oncol.

Tate, Shinichi, Kyoko Nishikimi, Ayumu Matsuoka, Satoyo Otsuka, Kazuyoshi Kato, Yutaka Takahashi, a Makio Shozu. "Tailored-dose Chemotherapy With Gemcitabine and Irinotecan in Patients With Platinum-refractory/resistant Ovarian or Primary Peritoneal Cancer: A Phase II Trial." J Gynecol Oncol 2020.

Tate, Shinichi, et al. "Tailored-dose Chemotherapy With Gemcitabine and Irinotecan in Patients With Platinum-refractory/resistant Ovarian or Primary Peritoneal Cancer: A Phase II Trial." J Gynecol Oncol 2020.